Type / Class
Equity / Ordinary Shares, par value Euro 0.01 per share
Shares outstanding
78.1M
Number of holders
40
Total 13F shares, excl. options
27.4M
Shares change
-721K
Total reported value, excl. options
$313M
Value change
-$8.25M
Number of buys
20
Number of sells
-13
Price
$11.52

Significant Holders of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) as of Q3 2024

42 filings reported holding ABVX - Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share as of Q3 2024.
Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.4M shares of 78.1M outstanding shares and own 35.04% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (6.06M shares), Deep Track Capital, LP (3.58M shares), Cormorant Asset Management, LP (2.13M shares), GREAT POINT PARTNERS LLC (2.13M shares), Blackstone Inc. (1.52M shares), VR Adviser, LLC (1.35M shares), FRANKLIN RESOURCES INC (1.32M shares), COMMODORE CAPITAL LP (1.28M shares), Nantahala Capital Management, LLC (986K shares), and Samsara BioCapital, LLC (850K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.